Supply and Support of Complete Antibody Quantification Testing Systems

NHS Blood and Transplant (NHSBT)contractFind a TenderRef ocds-h6vhtk-04fb3eProcurement Act 2023SME suitablepending
View buyer

Estimated value

Awarded value

£2.2m

Awarded 17 Feb 2026

Suppliers

1

1 SME

Lots

1

1 awarded

Published

18 Feb 2026

Description

Anti-D and Anti-c Antibody Quantification NHS Blood & Transplant (NHSBT) Red Cell Immunohaematology (RCI) function is seeking to provide a range of reference services to hospitals, focusing on ensuring safe and effective blood transfusions by diagnosing and managing complex issues related to red blood cells. Antibody (anti-D and anti-c) quantification is a vital component of RCI service, predominantly providing service to NHS hospitals. The test results play a crucial role in guiding the clinical management of alloimmunised ANC patients’ by predicting the risk of haemolytic disease of the foetus and newborn and triggering referral to an FMU specialist, In addition, quantification is used to assist in the laboratory differentiation of immune anti-D from passive anti-D Ig. The test is vital for identifying levels of alloimmune and prophylactic anti-D, as well as alloimmune anti-c in obstetric and other referrals.

Scope

Reference
C350958
Commercial tool
Standalone contract
Contract dates
31 Mar 2026 to 31 Mar 2033

Three additional years available as monthly or cumulative extensions.

CPV classifications
33100000
Particular suitability
Small and medium-sized enterprises (SME)

Award criteria

Criteria the buyer will use to evaluate bids.

NameDescriptionTypeWeighting
QualityQualityquality40.00%
PricePriceprice60.00%

Participation

Conditions suppliers must meet to bid.

The final requirements will be set out in the Tender Notice (UK04) and the Tender Documents when published (estimated 2nd September 2025).

Submission & procedure

Procedure
Competitive flexible procedure

Award details

Awarded supplier(s), contract period and value as published in the award notice.

Awarded value

£2.2m

Award date

17 Feb 2026

Contract start

31 Mar 2026

Contract end

31 Mar 2033